StockData
Labcorp Holdings Inc. logo

Labcorp Holdings Inc. (LH) stock

LHNYSEServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 11/3017% above fair value
$367.13−1.75 (-0.47%)

Close on Nov 20, 2026Market cap $29.81BP/E 30.1Yield 0.78%

Labcorp free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Labcorp's free cash flow for the twelve months ending Sep 30, 2026 was $1.29B, down 6.8% year over year. For fiscal 2025 it was $1.21B, up 10.0% from the year before. Over ten years it grew 5.2% a year on average. The highest annual figure on record is $2.69B in fiscal 2021.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.21B+10.0%
FY2024Dec 31, 2024$1.10B+25.4%
FY2023Dec 31, 2023$874.10M-42.7%
FY2022Dec 31, 2022$1.53B-43.2%
FY2021Dec 31, 2021$2.69B+53.3%
FY2020Dec 31, 2020$1.75B+67.9%
FY2019Dec 31, 2019$1.04B+12.8%
FY2018Dec 31, 2018$925.60M-21.9%
FY2017Dec 31, 2017$1.19B+29.1%
FY2016Dec 31, 2016$918.20M+26.4%
FY2015Dec 31, 2015$726.60M+35.7%
FY2014Dec 31, 2014$535.50M-13.1%
FY2013Dec 31, 2013$616.50M-7.7%
FY2012Dec 31, 2012$667.60M-6.0%
FY2011Dec 31, 2011$709.90M-6.3%
FY2010Dec 31, 2010$757.50M+1.3%
FY2009Dec 31, 2009$747.70M+19.8%
FY2008Dec 31, 2008$624.20M+10.1%
FY2007Dec 31, 2007$567.10M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$412.20M+47.0%
Q2 FY2026Jun 30, 2026$313.90M-42.2%
Q1 FY2026Mar 31, 2026$70.50M–
Q4 FY2025Dec 31, 2025$490.30M-26.3%
Q3 FY2025Sep 30, 2025$280.50M+73.7%
Q2 FY2025Jun 30, 2025$542.70M+25.4%
Q1 FY2025Mar 31, 2025-$107.50M–
Q4 FY2024Dec 31, 2024$665.10M+61.3%
Q3 FY2024Sep 30, 2024$161.50M-5.3%
Q2 FY2024Jun 30, 2024$432.90M+74.5%
Q1 FY2024Mar 31, 2024-$163.60M-480.5%
Q4 FY2023Dec 31, 2023$412.40M-25.6%
Q3 FY2023Sep 30, 2023$170.60M-41.4%
Q2 FY2023Jun 30, 2023$248.10M-43.9%
Q1 FY2023Mar 31, 2023$43.00M-82.0%
Q4 FY2022Dec 31, 2022$554.50M-5.4%
Q3 FY2022Sep 30, 2022$291.00M-55.2%
Q2 FY2022Jun 30, 2022$442.30M+13.4%
Q1 FY2022Mar 31, 2022$238.80M-77.5%
Q4 FY2021Dec 31, 2021$586.40M-13.2%
Q3 FY2021Sep 30, 2021$649.50M-8.4%
Q2 FY2021Jun 30, 2021$390.00M+43.3%
Q1 FY2021Mar 31, 2021$1.06B+992.8%
Q4 FY2020Dec 31, 2020$675.20M+52.9%
Q3 FY2020Sep 30, 2020$709.00M+95.3%
Q2 FY2020Jun 30, 2020$272.20M+61.7%
Q1 FY2020Mar 31, 2020$97.20M+35.8%
Q4 FY2019Dec 31, 2019$441.60M+21.3%
Q3 FY2019Sep 30, 2019$363.00M+135.7%
Q2 FY2019Jun 30, 2019$168.30M-43.9%
Q1 FY2019Mar 31, 2019$71.60M-33.2%
Q4 FY2018Dec 31, 2018$364.20M-22.3%
Q3 FY2018Sep 30, 2018$154.00M-52.1%
Q2 FY2018Jun 30, 2018$300.20M+24.5%
Q1 FY2018Mar 31, 2018$107.20M-30.3%
Q4 FY2017Dec 31, 2017$468.90M+18.5%
Q3 FY2017Sep 30, 2017$321.40M–
Q2 FY2017Jun 30, 2017$241.20M–
Q1 FY2017Mar 31, 2017$153.70M–
Q4 FY2016Dec 31, 2016$395.80M–

More Labcorp figures

See a number that looks wrong?